# Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

> **NCT00763022** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 302 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** TAK-559
- **DRUG:** TAK-559
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00763022
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2012-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763022, "Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00763022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*